Article ID Journal Published Year Pages File Type
1372072 Bioorganic & Medicinal Chemistry Letters 2010 4 Pages PDF
Abstract

With the goal of improving metabolic stability and further enhancing FBPase inhibitory activity, a series of tricyclic 8H-indeno[1,2-d][1,3]thiazoles was designed and synthesized with the aid of structure-based drug design. Extensive SAR studies led to the discovery of 19a with an IC50 value of 1 nM against human FBPase. X-ray crystallographic studies revealed that high affinity of 19a was due to the hydrophobic interaction arising from better shape complementarity and to the hydrogen bonding network involving the side chain on the tricyclic scaffold.

Graphical abstractOur structure-based drug design efforts led to the finding of 19a as potent FBPase inhibitor (FBPase IC50 = 1 nM).Figure optionsDownload full-size imageDownload as PowerPoint slide

Keywords
Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, , , , , , ,